← Open Payments lookup

TAYLOR KRINGS: Open Payments

NPI 1598376279 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,388 in 158 payments from 21 companies in 2025. Trend: 2023 $2,048 · 2024 $2,266 · 2025 $3,388

Food & beverage: $3,256Education: $132
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP23$533
Regeneron Healthcare Solutions, Inc.20$488
GENZYME CORPORATION12$434
Genentech USA, Inc.9$248
GlaxoSmithKline, LLC.17$219
Takeda Pharmaceuticals U.S.A., Inc.8$197
Amgen Inc.11$175
Novartis Pharmaceuticals Corporation12$173
ARS Pharmaceuticals Operations, Inc.11$163
LEO Pharma Inc.6$147

Products named: DUPIXENT, TEZSPIRE, Xolair, FASENRA, OCTAGAM IMMUNE GLOBULIN (HUMAN), HYQVIA, NEFFY, ADBRY.

Industry payments across TX — which companies pay providers there.